Abstract
This chapter summarizes the surgical strategies for adenocarcinomas of the distal esophagus, gastric cardia, and subcardial gastric cancer invading the cardia ± distal esophagus known as adenocarcinomas of the esophagogastric junction (AEG). The different surgical approaches according to the tumor origin, localization, and tumor stage are addressed with particular attention to the extent and type of resection and appropriate lymphadenectomy (LAD). The classification of AEG according to Siewert is helpful for the selection of the surgical strategy. While type I tumors benefit from a transthoracic en bloc esophagectomy including a two-field LAD, type II and III tumors can be treated by an extended total gastrectomy with a transhiatal resection of the distal esophagus and LAD of the lower mediastinum and the abdominal D2 compartment. Limited resections appear to be possible for early tumor stages in selected cases of type I–III tumors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aikou T, Shimazu H (1989) Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 19(3):290–295
Aikou T, Higashi H, Natsugoe S et al (2001) Can sentinel node navigation surgery reduce the extent of lymph node dissection in gastric cancer? Ann Surg Oncol 8(9 suppl):90S–93S
Altorki N, Kent M, Ferrara C et al (2002) Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg 236(2):177–183
Bartels H, Stein HJ, Siewert JR (1998) Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 85(6):840–844
Bizekis C, Kent MS, Luketich JD et al (2006) Initial experience with minimally invasive Ivor Lewis esophagectomy. Ann Thorac Surg 82(2):402–406; discussion 406–407
Bo T, Zhihong P, Peiwu Y et al (2009) General complications following laparoscopic-assisted gastrectomy and analysis of techniques to manage them. Surg Endosc 23:1860–1865
Bollschweiler E, Baldus SE, Schroder W et al (2006) High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 38(2):149–156
Bonenkamp JJ, Hermans J, Sasako M et al (1999) Extended lymph-node dissection for gastric cancer. N Engl J Med 340(12):908–914
Burian M, Stein HJ, Sendler A et al (2004) Sentinel node detection in Barrett’s and cardia cancer. Ann Surg Oncol 11(3 Suppl):255S–258S
Cense HA, Visser MR, van Sandick JW et al (2004) Quality of life after colon interposition by necessity for esophageal cancer replacement. J Surg Oncol 88(1):32–38
D’Journo XB, Doddoli C, Michelet P et al (2005) Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy? Eur J Cardiothorac Surg 27(4):697–704
D’Journo XB, Ferraro P, Martin J et al (2009) Barrett’s esophagus in the esophageal remnant: a critical long-term complication of subtotal esophagectomy. Ann Surg Oncol 16(5):1429; author reply 1430–1431
Dresner SM, Griffin SM (2000) Pattern of recurrence following radical oesophagectomy with two-field lymphadenectomy. Br J Surg 87(10):1426–1433
Ell C, May A, Gossner L et al (2000) Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 118(4):670–677
Feith M, Stein HJ, Siewert JR (2006) Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients. Surg Oncol Clin N Am 15(4):751–764
Gall FP, Hermanek P (1985) New aspects in the surgical treatment of gastric carcinoma–a comparative study of 1636 patients operated on between 1969 and 1982. Eur J Surg Oncol 11(3):219–225
Griffith JP, Sue-Ling HM, Martin I et al (1995) Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 36(5):684–690
Hofstetter W, Correa AM, Bekele N et al (2007) Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg 84(2):365–373; discussion 374–375
Holscher AH, Bollschweiler E, Schneider PM et al (1997) Early adenocarcinoma in Barrett’s oesophagus. Br J Surg 84(10):1470–1473
Holscher AH, Schroder W, Bollschweiler E et al (2003) [How safe is high intrathoracic esophagogastrostomy?]. Chirurg 74(8):726–733
Holscher AH, Schneider PM, Gutschow C et al (2007) Laparoscopic ischemic conditioning of the stomach for esophageal replacement. Ann Surg 245(2):241–246
Hulscher JB, van Sandick JW, Tijssen JG et al (2000) The recurrence pattern of esophageal carcinoma after transhiatal resection. J Am Coll Surg 191(2):143–148
Hulscher JB, van Sandick JW, de Boer AG et al (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347(21):1662–1669
Katai H, Sano T, Fukagawa T et al (2003) Prospective study of proximal gastrectomy for early gastric cancer in the upper third of the stomach. Br J Surg 90(7):850–853
Kitagawa Y, Kitano S, Kubota T et al (2005a) Minimally invasive surgery for gastric cancer–toward a confluence of two major streams: a review. Gastric Cancer 8(2):103–110
Kitagawa Y, Fujii H, Mukai M et al (2005b) Sentinel lymph node mapping in esophageal and gastric cancer. Cancer Treat Res 127:123–139
Kitajima M, Kitagawa Y, Fujii H et al (2005) Credentialing of nuclear medicine physicians, surgeons, and pathologists as a multidisciplinary team for selective sentinel lymphadenectomy. Cancer Treat Res 127:253–267
Kulig J, Popiela T, Kolodziejczyk P et al (2007) Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193(1):10–15
Lauren PA, Nevalainen TJ (1993) Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 71(10):2926–2933
Lerut T, Nafteux P, Moons J et al (2004) Three-field lymphadenectomy for carcinoma of the esophagus and gastroesophageal junction in 174 R0 resections: impact on staging, disease-free survival, and outcome: a plea for adaptation of TNM classification in upper-half esophageal carcinoma. Ann Surg 240(6):962–972; discussion 972–974
Maruyama K, Gunven P, Okabayashi K et al (1989) Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg 210(5):596–602
Merendino KA, Dillard DH (1955) The concept of sphincter substitution by an interposed jejunal segment for anatomic and physiologic abnormalities at the esophagogastric junction; with special reference to reflux esophagitis, cardiospasm and esophageal varices. Ann Surg 142(3):486–506
Motoyama S, Saito R, Okuyama M et al (2006) Treating gastric tube cancer with distal gastrectomy preserving the gastroepiploic artery. Ann Thorac Surg 81(2):751–753
Nakajima M, Kato H, Miyazaki T et al (2007) Comprehensive investigations of quality of life after esophagectomy with special reference to the route of reconstruction. Hepatogastroenterology 54(73):104–110
Nguyen NT, Hinojosa MW, Smith BR et al (2008) Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg 248(6):1081–1091
Nishihira T, Hirayama K, Mori S (1998) A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg 175(1):47–51
Omloo JM, Lagarde SM, Hulscher JB et al (2007) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg 246(6):992–1000; discussion 1000–1001
Ozawa S, Ando N, Kitagawa Y et al (1998) [Does incidence of carcinoma of the esophagogastric junction increase?]. Nippon Geka Gakkai Zasshi 99(9):542–546
Pech O, Ell C (2009) Endoscopic therapy of Barrett’s esophagus. Curr Opin Gastroenterol 25:405–411
Pera M, Manterola C, Vidal O et al (2005) Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92(3):151–159
Peyre CG, Hagen JA, DeMeester SR et al (2008a) The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg 248(4):549–556
Peyre CG, Hagen JA, DeMeester SR et al (2008b) Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodes. Ann Surg 248(6):979–985
Portale G, Hagen JA, Peters JH et al (2006) Modern 5-year survival of resectable esophageal adenocarcinoma: single institution experience with 263 patients. J Am Coll Surg 202(4):588–596; discussion 596–598
Sasako M, Sano T, Yamamoto S et al (2006) Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial. Lancet Oncol 7(8):644–651
Sauvanet A, Mariette C, Thomas P et al (2005) Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors. J Am Coll Surg 201(2):253–262
Scheepers JJ, van der Peet DL, Veenhof AA et al (2009) Systematic approach of postoperative gastric conduit complications after esophageal resection. Dis Esophagus 2009.
Schroder W, Monig SP, Baldus SE et al (2002) Frequency of nodal metastases to the upper mediastinum in Barrett’s cancer. Ann Surg Oncol 9(8):807–811
Schuchert MJ, Luketich JD, Landreneau RJ et al (2008) Minimally-invasive esophagomyotomy in 200 consecutive patients: factors influencing postoperative outcomes. Ann Thorac Surg 85(5):1729–1734
Schuhmacher C, Novotny A, Ott K et al (2007) [Lymphadenectomy with tumors of the upper gastrointestinal tract]. Chirurg 78(3):203–206, 208–212, 214–216
Siewert JR, Stein HJ (1998) Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg 85(11):1457–1459
Siewert JR, Holscher AH, Becker K et al (1987) [Cardia cancer: attempt at a therapeutically relevant classification]. Chirurg 58(1):25–32
Siewert J, Feith M, Werner M et al (2000) Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients. Ann Surg 232(3):9
Siewert JR, Stein HJ, Feith M et al (2001) Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001 234(3):360–367; discussion 368–369
Stein HJ, Feith M, Mueller J et al (2000) Limited resection for early adenocarcinoma in Barrett’s esophagus. Ann Surg 232(6):733–742
Stein HJ, Bartels H, Siewert JR (2001) Esophageal carcinoma: 2-stage operation for preventing mediastinitis in high risk patients. Chirurg 72(8):881–886
Tachimori Y, Kanamori N, Uemura N et al (2009) Salvage esophagectomy after high-dose chemoradiotherapy for esophageal squamous cell carcinoma. J Thorac Cardiovasc Surg 137(1):49–54
Yuasa N, Miyake H, Yamada T et al (2006) Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction. World J Surg 30(3):364–371
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Schiesser, M., Schneider, P.M. (2009). Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction. In: Schneider, P. (eds) Adenocarcinoma of the Esophagogastric Junction. Recent Results in Cancer Research, vol 182. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70579-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-70579-6_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70578-9
Online ISBN: 978-3-540-70579-6
eBook Packages: MedicineMedicine (R0)